Funding Rounds
ENYO Pharma Series C (2024, $42M)
ENYO PharmaVonafexor drug maker for the treatment of Alport syndrome.
Summary
Stage: Series C
Raised Amount: $42.57M
Raised Date: 2024-03-01
Stage: Series C
Raised Amount: $42.57M
Raised Date: 2024-03-01
